0000000000821495

AUTHOR

José I. Botella-carretero

showing 2 related works from this author

White fish reduces cardiovascular risk factors in patients with metabolic syndrome: the WISH-CARE study, a multicenter randomized clinical trial.

2013

Reduction of cardiovascular risk with high consumption of fish in diet is still a matter of debate, and concerns about heavy metal contamination have limited consumption of oily fish. We aimed to evaluate the effect of regular ingestion of white fish on cardiovascular risk factors in patients with metabolic syndrome.Multicenter randomized crossover clinical trial including 273 individuals with metabolic syndrome. An 8-week only-one dietary intervention: 100 g/d of white fish (Namibia hake) with advice on a healthy diet, compared with no fish or seafood with advice on a healthy diet. Outcomes were lipid profile, individual components of the metabolic syndrome, serum insulin concentrations, h…

Malemedicine.medical_specialtyWaistMeatEndocrinology Diabetes and MetabolismMedicine (miscellaneous)PhysiologyBlood Pressurelaw.inventionBody Mass Indexchemistry.chemical_compoundInsulin resistanceRandomized controlled triallawRisk FactorsInternal medicinemedicineOily fishAnimalsHumansInsulinTriglyceridesAgedMetabolic SyndromeNutrition and DieteticsTriglyceridemedicine.diagnostic_testbusiness.industryCholesterol HDLFatty AcidsFishesCholesterol LDLMiddle Agedmedicine.diseaseDietBlood pressureEndocrinologyC-Reactive ProteinTreatment OutcomechemistrySeafoodCardiovascular DiseasesFemaleMetabolic syndromeInsulin ResistanceWaist CircumferenceCardiology and Cardiovascular MedicineLipid profilebusinessNutrition, metabolism, and cardiovascular diseases : NMCD
researchProduct

A body weight loss- and health-promoting gut microbiota is established after bariatric surgery in individuals with severe obesity

2020

Obesity has reached an epidemic level worldwide, and bariatric surgery (BS) has been proven to be the most efficient therapy to reduce severe obesity-related comorbidities. Given that the gut microbiota plays a causal role in obesity development and that surgery may alter the gut environment, investigating the impact of BS on the microbiota in the context of severe obesity is important. Although, alterations at the level of total gut bacteria, total gene content and total metabolite content have started to be disentangled, a clear deficit exists regarding the analysis of the active fraction of the microbiota, which is the fraction that is most reactive to the BS. Here, active gut microbiota…

medicine.medical_specialtySleeve gastrectomymedicine.medical_treatmentClinical BiochemistryGastric BypassPharmaceutical ScienceBariatric SurgeryContext (language use)Gut flora01 natural sciencesAnalytical ChemistryMetabolomicsDetoxificationDrug DiscoveryWeight LossmedicineHumansMicrobiomeSpectroscopybiology010405 organic chemistryChemistry010401 analytical chemistryMetabolismmedicine.diseasebiology.organism_classificationObesity0104 chemical sciencesSurgeryGastrointestinal MicrobiomeObesity Morbid
researchProduct